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SGC is a heme containing heterodimer having two known
active isoforms, α1β1 and α2β1. Particularly the former is
suspected to be important in smooth muscle relaxation
while the latter would be involved in neurologic systems.
Since no isoform specific inhibitors exist, we generated
knockout mice for the α1 isoform in order to investigate
its function in the systems involving the NO/sGC path-
way. The deletion of exon 6 resulted in mice expressing a
non-frameshifted inactive protein. Hence the mice could
be considered as cyclase death knockins, avoiding pheno-
types due to enzyme function independent structural
functions of the protein. We observed that these knockout
mice retained full viability and fertility. The male mice
developed hypertension around 12 to 14 weeks of age
while the female mice did not. Ovariectomy did not influ-
ence the blood pressure in a different way than in wild
type littermate controls. Both in the male and female
knockout mice the NOS-inhibitor L-NAME raised the
blood pressure to a similar extent as in wild type mice.
NO-donors lowered blood pressure in male but not
female mice. These observations show that the impor-
tance of the NO/sGC system in blood pressure regulation
is gender-specific and that in female mice other mecha-
nisms, probably EDHF, play the major role. It further-
more demonstrates that NO has sGCα1β1 independent
activities in blood pressure regulation, either acting
through the sGCα2β1 isoform or through sGC independ-
ent mechanisms such as direct influence on K+ channels.
Phenotyping in a NOS-1 dependent system showed that
α1β1 is also involved in NOS-1 derived NO signalling.
In parallel experiments in supposedly NOS dependent
shock models that could be inhibited by methylene blue
we observed that the shock was retained even in the
absence of NO, and based upon ion channel inhibition,
probably is due to (an) EDHF.
Taken together, these data show that our current concepts
on both normal blood pressure regulation and vasodila-
tory shock are too simple, and that also in these phenom-
ena sGC independent effects of NO and NO independent
inflammatory shock mechanisms should be taken into
account. Also the specific role of the sGC isoforms is only
at the beginning of its elucidation.
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